Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer

Oncogene

Volumn 32, Issue 42, 2013, Pages 5111-5122

  Pandey, P R ^a   Xing, F ^a,c   Sharma, S ^a   Watabe, M ^a   Pai, S K ^a   Iiizumi Gairani, M ^a   Fukuda, K ^a   Hirota, S ^b   Mo, Y Y ^c   Watabe, K ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Breast cancer; Ductal carcinoma in situ; Lipogenesis; Resveratrol; Stem like cells

Indexed keywords

CD44V ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; RESVERATROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER STEM CELL; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; LIPOGENESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOGENESIS; MICE; MICE, NUDE; STEM CELLS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 84886098968     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.519     Document Type: Article

References (46)

1. Barnes NL, Ooi JL, Yarnold JR, Bundred NJ. Ductal carcinoma in situ of the breast. BMJ 2012; 344: e797.
2. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 61: 5697-5702 2001. (Pubitemid 32769079)
3. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003; 100: 5974-5979. (Pubitemid 36576916)
4. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-777. (Pubitemid 47469806)
5. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006; 9: 358-365. (Pubitemid 44101970)
6. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125-1131. (Pubitemid 34496588)
7. Rashid A, Pizer ES, Moga M et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997; 150: 201-208. (Pubitemid 27027110)
8. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997; 3: 2115-2120. (Pubitemid 27505140)
9. Pizer ES, Chrest FJ, Di Giuseppe JA, Han WF. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 1998; 58: 4611-4615. (Pubitemid 28480625)
10. Bandyopadhyay S, Zhan R, Wang Y, Pai SK, Hirota S, Hosobe S et al. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res 2006; 66: 5934-5940. (Pubitemid 43927149)
11. Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat 2011; 130: 387-398.
12. Pandey PR, Liu W, Xing F, Fukuda K, Watabe K. Anti-cancer drugs targeting fatty acid synthase (FAS). Recent Pat Anticancer Drug Discov 2012; 7: 185-197.
13. Liu W, Furuta E, Shindo K, Watabe M, Xing F, Pandey PR et al. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBPFAS signaling pathway. Breast Cancer Res Treat 2011; 128: 57-68.
14. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988. (Pubitemid 36418143)
15. Heppner GH, Wolman SR. MCF-10AT: a model for human breast cancer development. Breast J 1999; 5: 122-129. (Pubitemid 29183819)
16. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 1996; 148: 313-319.
17. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ et al. Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 1993; 85: 1725-1732. (Pubitemid 23320842)
18. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001; 40: 439-452. (Pubitemid 32929966)
19. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89: 331-340. (Pubitemid 27220877)
20. Yamashita T, Honda M, Takatori H, Nishino R, Minato H, Takamura H et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50: 100-110.
21. Huang WC, Li X, Liu J, Lin J, Chung LW. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res 2012; 10: 133-142.
22. Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res 2008; 68: 1003-1011. (Pubitemid 351278386)
23. Damonte P, Hodgson JG, Chen JQ, Young LJ, Cardiff RD, Borowsky AD. Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Res 2008; 10: R50.
24. Menendez JA, Lupu R. Oncogenic properties of the endogenous fatty acid metabolism: Molecular pathology of fatty acid synthase in cancer cells. Curr Opin Clin Nutr Metab Care 2006; 9: 346-357. (Pubitemid 44101969)
25. Esslimani-Sahla M, Thezenas S, Siminy-Lafontaine J, Kramar A, Lavaill R, Chalbos D et al. Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis. Int J Cancer 2007; 120: 224-229. (Pubitemid 44970426)
26. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 2000; 31: 1068-1073.
27. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 2004; 91: 47-53.
28. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 2009; 101: 519-532.
29. Alberola-Ila J, Hernandez-Hoyos G. The Ras/MAPK cascade and the control of positive selection. Immunol Rev 2003; 191: 79-96. (Pubitemid 36398850)
30. Ramjaun AR, Downward J. Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 2007; 6: 2902-2905.
31. McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE et al. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 2006; 46: 249-279. (Pubitemid 44301348)
32. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI (3) K and PKB. Nature 1997; 385: 544-548. (Pubitemid 27074674)
33. Carón RW, Yacoub A, Mitchell C, Zhu X, Hong Y, Sasazuki T et al. Radiationstimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells. Cell Cycle 2005; 4: 456-464. (Pubitemid 41359734)
34. Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell prolif 2008; 41: 59-85. (Pubitemid 351147647)
35. Valverde AM, Navarro P, Benito M, Lorenzo M. H-ras induces glucose uptake in brown adipocytes in an insulin- and phosphatidylinositol 3-kinase-independent manner. Exp Cell Res 1998; 243: 274-281. (Pubitemid 28488838)
36. Guillet-Deniau I, Pichard AL, Koné A, Esnous C, Nieruchalski M, Girard J et al. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterolregulatory-element-binding-protein-1c-dependent pathway. J Cell Sci 2004; 117: 1937-1944. (Pubitemid 38745127)
37. Uttarwar L, Gao B, Ingram AJ, Krepinsky JC. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells. Am J Physiol Renal Physiol 2012; 302: 329-341.
38. Janes PW, Daly RJ, deFazio A, Sutherland RL. Activation of the Ras signaling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994; 9: 3601-3608. (Pubitemid 24359398)
39. Von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. Ras activation in human breast cancer. Breast Cancer Res Treat 2000; 62: 51-62. (Pubitemid 30609563)
40. Lee CM, Shrieve DC, Zempolich KA, Lee RJ, Hammond E, Handrahan DL et al. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix. Gynecol Oncol 2005; 99: 415-421. (Pubitemid 41502854)
41. Chuthapisith S, Eremin J, El-Sheemey M, Eremin O. Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol 2010; 19: 27-32.
42. Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, Van Buren II G et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009; 69: 1951-1957.
43. Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 2006; 98: 1755-1757. (Pubitemid 46017927)
44. Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67: 4807-4815. (Pubitemid 46910189)
45. Allan AL, Vantyghem SA, Tuck AB, Chambers AF. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis 2007; 26: 87-98.
46. Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S et al. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res 2012; 72: 537-547.